Subscribe To
Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...
September 27, 2023, 8:05 pm
Synlogic announces reverse stock split
CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non...
September 27, 2023, 4:30 pm
Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting
SAN CARLOS, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, de...
September 27, 2023, 4:01 pm
Allogene therapeutics announces three poster presentations from its next generation allocar t™ platform at the society for immunotherapy of cancer (sitc) annual meeting
Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells Demonstration of Dagger™ Technolog...
September 27, 2023, 1:09 pm
Mainz biomed to present detailed results of colofuture study at international conference on gastroenterology
Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal c...
September 27, 2023, 8:01 am
Hillevax to participate in fireside chat at the 2023 cantor global healthcare conference
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerc...
September 26, 2023, 4:01 pm
Novo nordisk (nvo), valo ink deal to develop heart disease drugs
Novo Nordisk (NVO) collaborates with Valo Health to discover and develop novel treatments for cardiomet...
September 26, 2023, 11:17 am
Galectin therapeutics to present update on its belapectin liver cirrhosis program at the 20th edition of discovery on target meeting, in boston, september 25-28, 2023
NORCROSS, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target gale...
September 26, 2023, 8:00 am
Ultragenyx launches evkeeza® (evinacumab for injection) in canada for the treatment of homozygous familial hypercholesterolemia (hofh)
Evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an u...
September 25, 2023, 9:13 pm
Fca's big screen debut targets investment hype
The Financial Conduct Authority (FCA) is taking a novel approach to consumer education by premiering a ...
September 25, 2023, 2:28 pm
Soleno therapeutics to present at the cantor global healthcare conference
REDWOOD CITY, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical ...
September 25, 2023, 12:00 pm
Novo nordisk announces ai collaboration with valo health for cardiometabolic treatments
Novo Nordisk (NYSE:NVO) has announced a collaboration with Valo Health to discover and develop novel tr...
September 25, 2023, 9:51 am
Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy
SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...
September 25, 2023, 9:30 am
Week in review: everest acquires novel autoimmune therapy in $132 million agreement
Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from ...
September 24, 2023, 10:33 pm
Aytu biopharma to report fourth quarter and fiscal 2023 financial results on september 27, 2023
ENGLEWOOD, CO / ACCESSWIRE / September 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on comm...
September 21, 2023, 8:25 pm
Atreca announces agreement to terminate lease and departure of chief financial officer herb cross
SAN CARLOS, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on develo...
September 21, 2023, 12:00 pm
Janone to present at the dawson james 8th annual investment conference
Chief Medical Officer Dr. Amol Soin will explain innovative approaches to pain management and JanOne's development of non-addicting treatments for pai...
September 21, 2023, 11:30 am
Jasper therapeutics to present new positive data on briquilimab conditioning in patients with fanconi anemia at the 2023 fanconi anemia research fund scientific symposium
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...
September 21, 2023, 8:00 am
Frontier portfolio company signs collaboration deal with merck
Frontier IP Group PLC (AIM:FIPP), a firm specialising in the commercialisation of intellectual property, announced in an RNS today that its portfolio ...
September 21, 2023, 4:01 am
Veru to participate in fireside chat at the 2023 cantor fitzgerald global healthcare conference on september 28th, 2023
MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing ...
September 20, 2023, 12:30 pm